Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Niacin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 23 May 2013 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
- 22 May 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.